home / stock / cosm / cosm news


COSM News and Press, Cosmos Holdings Inc. From 09/13/23

Stock Information

Company Name: Cosmos Holdings Inc.
Stock Symbol: COSM
Market: NASDAQ
Website: cosmoshold.com

Menu

COSM COSM Quote COSM Short COSM News COSM Articles COSM Message Board
Get COSM Alerts

News, Short Squeeze, Breakout and More Instantly...

COSM - Cosmos Health Starts Stock Buyback Program

CHICAGO, IL / ACCESSWIRE / September 13, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer and distributor of h...

COSM - BestGrowthStocks.com issues New Growth Report on Cosmos Health

(NewsDirect) NEW YORK, NY / NewsDirect / September 13th, 2023 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a new growth report on Cosmos...

COSM - Cosmos Health expects to achieve revenue of more than $180M by 2026

2023-09-12 09:38:51 ET More on Cosmos Health Financial information for Cosmos Health Cosmos Health Non-GAAP EPS of $0.01, revenue of $12.36M Cosmos Health stock dips after it gets $5.25M financing For further details see: Cosmos Health expects to achieve ...

COSM - Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023

Company reaches major strategic inflection point, with operations and revenue ramp-up underway Inaugural 2026 guidance introduced; target to achieve: More than $180 million in gross annual revenue EBITDA in excess of $20 million So far in 2023, among other achievements: Completed...

COSM - Cosmos Holdings Non-GAAP EPS of $0.01, revenue of $12.36M

2023-08-15 09:27:30 ET Cosmos Holdings press release ( NASDAQ: COSM ): Q2 Non-GAAP EPS of $0.01. Revenue of $12.36M (-6.4% Y/Y). Notes payable (current portion) decreased by 59% to $0.89 million in Q2 2023 from $2.16 million in Q4 2022, and notes payable (long-term por...

COSM - Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04

CHICAGO, IL / ACCESSWIRE / August 15, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer and distributor of healthcare prod...

COSM - LifeMD, Precigen top healthcare gainers; Galera, Virios lead losers' pack

2023-08-10 10:27:32 ET Gainers: LifeMD ( LFMD ) +20% . Precigen ( PGEN ) +19% . Repare Therapeutics ( RPTX ) +16% . Cosmos Health ( COSM ) +13% . GoodRx Holdings ( GDRX ) +13% . Losers: Galera Therapeutics ( GRTX ) -...

COSM - Cosmos Health Appoints Big 4 Accounting Firm KPMG as Auditor

CHICAGO, IL / ACCESSWIRE / August 8, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today the ...

COSM - Cosmos Health Continues to Expand Mediterranation Brand, Welcomes Eleonas and Olympus Mons; Boosts Exports and Secures Purchase Orders, Including from Leading Multinational Health Food Chain

CHICAGO, IL / ACCESSWIRE / August 2, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today the ...

COSM - Cosmos Health Provides Update on Recent Developments, Maintains Strong Financial Position, Reaffirms Commitment to Growth, and Highlights CEO's Continued Investment Now Exceeds $15 Million

CHICAGO, IL / ACCESSWIRE / July 25, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today provided an upd...

Previous 10 Next 10